Ausgabe 2/2017
Molecular pathology in the era of precision medicine
Inhalt (16 Artikel)
Preparing pathology for precision medicine: challenges and opportunities
Karen L Kaul
Liquid biopsy: unlocking the potentials of cell-free DNA
David Chu, Ben Ho Park
Molecular mechanisms of therapy resistance in solid tumors: chasing “moving” targets
Laura J. Tafe
Early detection: the impact of genomics
M. C. J. van Lanschot, L. J. W. Bosch, M. de Wit, B. Carvalho, G. A. Meijer
Managing the genomic revolution in cancer diagnostics
Doreen Nguyen, Christopher D. Gocke
Erratum to: Managing the genomic revolution in cancer diagnostics
Doreen Nguyen, Christopher D. Gocke
The ins and outs of molecular pathology reporting
Véronique Tack, Kelly Dufraing, Zandra C. Deans, Han J. van Krieken, Elisabeth M. C. Dequeker
Immunogenomics: using genomics to personalize cancer immunotherapy
Rance C. Siniard, Shuko Harada
Lung cancer as a paradigm for precision oncology in solid tumours
Simon Schallenberg, Sabine Merkelbach-Bruse, Reinhard Buettner
Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm
Larissa V. Furtado, Wade S. Samowitz
Molecular profiling of sarcomas: new vistas for precision medicine
Tariq Al-Zaid, Wei-Lien Wang, Neeta Somaiah, Alexander J. Lazar
Characterization of gliomas: from morphology to molecules
Sean P. Ferris, Jeffrey W. Hofmann, David A. Solomon, Arie Perry
Toward personalized management in bladder cancer: the promise of novel molecular taxonomy
Marie-Lisa Eich, Lars Dyrskjøt, George J. Netto
Molecular genetic and immunotherapeutic targets in metastatic melanoma
C. Melis, A. Rogiers, O. Bechter, Joost J. van den Oord
HPV-related carcinomas of the head and neck: morphologic features, variants, and practical considerations for the surgical pathologist
Todd M. Stevens, Justin A. Bishop